Boehringer Ingelheim


Boehringer Ingelheim collaboration

We have entered into a multi-year drug discovery collaboration with Boehringer Ingelheim to jointly validate a new therapeutic concept with the aim of discovering novel therapeutic molecules for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic diseases.

This collaboration entitles Inventiva to receive research fees, milestones and sales royalties